List of Tables
Table 1. Global Chronic Granulomatous Disease (CGD) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of X-Linked Chronic Granulomatous Disease
Table 3. Key Players of Autosomal Recessive Chronic Granulomatous Disease
Table 4. Global Chronic Granulomatous Disease (CGD) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Chronic Granulomatous Disease (CGD) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Chronic Granulomatous Disease (CGD) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Region (2019-2024)
Table 8. Global Chronic Granulomatous Disease (CGD) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Region (2025-2030)
Table 10. Chronic Granulomatous Disease (CGD) Treatment Market Trends
Table 11. Chronic Granulomatous Disease (CGD) Treatment Market Drivers
Table 12. Chronic Granulomatous Disease (CGD) Treatment Market Challenges
Table 13. Chronic Granulomatous Disease (CGD) Treatment Market Restraints
Table 14. Global Chronic Granulomatous Disease (CGD) Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Players (2019-2024)
Table 16. Global Top Chronic Granulomatous Disease (CGD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Granulomatous Disease (CGD) Treatment as of 2023)
Table 17. Ranking of Global Top Chronic Granulomatous Disease (CGD) Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Chronic Granulomatous Disease (CGD) Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Granulomatous Disease (CGD) Treatment Product Solution and Service
Table 21. Date of Enter into Chronic Granulomatous Disease (CGD) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Granulomatous Disease (CGD) Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Chronic Granulomatous Disease (CGD) Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Chronic Granulomatous Disease (CGD) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Chronic Granulomatous Disease (CGD) Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Chronic Granulomatous Disease (CGD) Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Chronic Granulomatous Disease (CGD) Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Chronic Granulomatous Disease (CGD) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Chronic Granulomatous Disease (CGD) Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Chronic Granulomatous Disease (CGD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Chronic Granulomatous Disease (CGD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Chronic Granulomatous Disease (CGD) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Chronic Granulomatous Disease (CGD) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Chronic Granulomatous Disease (CGD) Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chronic Granulomatous Disease (CGD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Chronic Granulomatous Disease (CGD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Chronic Granulomatous Disease (CGD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Clinigen Group plc Company Detail
Table 47. Clinigen Group plc Business Overview
Table 48. Clinigen Group plc Chronic Granulomatous Disease (CGD) Treatment Product
Table 49. Clinigen Group plc Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 50. Clinigen Group plc Recent Development
Table 51. Orchard Therapeutics plc2032 Company Detail
Table 52. Orchard Therapeutics plc2032 Business Overview
Table 53. Orchard Therapeutics plc2032 Chronic Granulomatous Disease (CGD) Treatment Product
Table 54. Orchard Therapeutics plc2032 Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 55. Orchard Therapeutics plc2032 Recent Development
Table 56. Horizon Therapeutics plc Company Detail
Table 57. Horizon Therapeutics plc Business Overview
Table 58. Horizon Therapeutics plc Chronic Granulomatous Disease (CGD) Treatment Product
Table 59. Horizon Therapeutics plc Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 60. Horizon Therapeutics plc Recent Development
Table 61. ViroMed. Co. Ltd Company Detail
Table 62. ViroMed. Co. Ltd Business Overview
Table 63. ViroMed. Co. Ltd Chronic Granulomatous Disease (CGD) Treatment Product
Table 64. ViroMed. Co. Ltd Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 65. ViroMed. Co. Ltd Recent Development
Table 66. Bellicum Pharmaceuticals, Inc Company Detail
Table 67. Bellicum Pharmaceuticals, Inc Business Overview
Table 68. Bellicum Pharmaceuticals, Inc Chronic Granulomatous Disease (CGD) Treatment Product
Table 69. Bellicum Pharmaceuticals, Inc Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 70. Bellicum Pharmaceuticals, Inc Recent Development
Table 71. Pfizer Inc Company Detail
Table 72. Pfizer Inc Business Overview
Table 73. Pfizer Inc Chronic Granulomatous Disease (CGD) Treatment Product
Table 74. Pfizer Inc Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 75. Pfizer Inc Recent Development
Table 76. Hoffmann-La Roche Ltd Company Detail
Table 77. Hoffmann-La Roche Ltd Business Overview
Table 78. Hoffmann-La Roche Ltd Chronic Granulomatous Disease (CGD) Treatment Product
Table 79. Hoffmann-La Roche Ltd Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 80. Hoffmann-La Roche Ltd Recent Development
Table 81. Novartis AG Company Detail
Table 82. Novartis AG Business Overview
Table 83. Novartis AG Chronic Granulomatous Disease (CGD) Treatment Product
Table 84. Novartis AG Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 85. Novartis AG Recent Development
Table 86. Lonza Company Detail
Table 87. Lonza Business Overview
Table 88. Lonza Chronic Granulomatous Disease (CGD) Treatment Product
Table 89. Lonza Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 90. Lonza Recent Development
Table 91. GlaxoSmithKline plc Company Detail
Table 92. GlaxoSmithKline plc Business Overview
Table 93. GlaxoSmithKline plc Chronic Granulomatous Disease (CGD) Treatment Product
Table 94. GlaxoSmithKline plc Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 95. GlaxoSmithKline plc Recent Development
Table 96. Eli Lilly and Company Company Detail
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Chronic Granulomatous Disease (CGD) Treatment Product
Table 99. Eli Lilly and Company Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 100. Eli Lilly and Company Recent Development
Table 101. Johnson & Johnson Services, Inc Company Detail
Table 102. Johnson & Johnson Services, Inc Business Overview
Table 103. Johnson & Johnson Services, Inc Chronic Granulomatous Disease (CGD) Treatment Product
Table 104. Johnson & Johnson Services, Inc Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 105. Johnson & Johnson Services, Inc Recent Development
Table 106. Merck KGaA Company Detail
Table 107. Merck KGaA Business Overview
Table 108. Merck KGaA Chronic Granulomatous Disease (CGD) Treatment Product
Table 109. Merck KGaA Revenue in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024) & (US$ Million)
Table 110. Merck KGaA Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Granulomatous Disease (CGD) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Type: 2023 VS 2030
Figure 3. X-Linked Chronic Granulomatous Disease Features
Figure 4. Autosomal Recessive Chronic Granulomatous Disease Features
Figure 5. Global Chronic Granulomatous Disease (CGD) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Application: 2023 VS 2030
Figure 7. Neutrophil Function Tests Case Studies
Figure 8. Genetic Testing Case Studies
Figure 9. Prenatal Testing Case Studies
Figure 10. Chronic Granulomatous Disease (CGD) Treatment Report Years Considered
Figure 11. Global Chronic Granulomatous Disease (CGD) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Chronic Granulomatous Disease (CGD) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Chronic Granulomatous Disease (CGD) Treatment Market Share by Players in 2023
Figure 15. Global Top Chronic Granulomatous Disease (CGD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Granulomatous Disease (CGD) Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Chronic Granulomatous Disease (CGD) Treatment Revenue in 2023
Figure 17. North America Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Chronic Granulomatous Disease (CGD) Treatment Market Share by Country (2019-2030)
Figure 19. United States Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Chronic Granulomatous Disease (CGD) Treatment Market Share by Country (2019-2030)
Figure 23. Germany Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Chronic Granulomatous Disease (CGD) Treatment Market Share by Region (2019-2030)
Figure 31. China Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Chronic Granulomatous Disease (CGD) Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Chronic Granulomatous Disease (CGD) Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Chronic Granulomatous Disease (CGD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Clinigen Group plc Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 46. Orchard Therapeutics plc2032 Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 47. Horizon Therapeutics plc Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 48. ViroMed. Co. Ltd Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 49. Bellicum Pharmaceuticals, Inc Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 50. Pfizer Inc Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 51. Hoffmann-La Roche Ltd Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 52. Novartis AG Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 53. Lonza Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 54. GlaxoSmithKline plc Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 56. Johnson & Johnson Services, Inc Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 57. Merck KGaA Revenue Growth Rate in Chronic Granulomatous Disease (CGD) Treatment Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed